Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor expression in human lung

Linda J. Kay, S. Kim Suvarna, Anne Marie Scola, Amin Rostami-Hodjegan, Russell Chess-Williams, Peter T. Peachell

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: The aim of the present study was to establish whether polymorphisms, especially those within the promoter region, of the β2-adrenoceptor gene (ADRB2) influence β2-adrenoceptor expression in human lung. Methods: The density of β-adrenoceptors in human lung tissue (n = 88) was determined by saturation binding using the radioligand, iodinated cyanopindolol. Discrimination of β1- and β2-adrenoceptors was determined using the highly selective β1-adrenoceptor antagonist, CGP20712A. Genotype was determined at 5 positions of ADRB2 previously reported as polymorphic. Potential influences of single nucleotide polymorphisms (SNPs) within the promoter region (-367, -47) and coding block (46, 79, 491) of ADRB2 on β2-adrenoceptor expression were investigated. Results: The density of β2-adrenoceptors was variable among the 88 lung preparations studied ranging from 17 to 177 fmol/mg protein (mean ± S.E.M., 72 ± 4 fmol/mg protein). There was no influence of genotype on β2-adrenoceptor expression for any of the polymorphisms studied except at position 491. The polymorphism at position 491C > T, leading to a change from thr to ile at amino acid 164, is uncommon. Preparations genotyped as heterozygous (126 ± 15 fmol/mg protein; n = 5) expressed significantly (P = 0.0005) higher levels of β2-adrenoceptor than those that were homozygous (69 ± 4 fmol/mg protein; n = 83). Conclusion: With the exception of position 491, these data indicate that polymorphisms of ADRB2 do not influence β2-adrenoceptor expression in human lung. Crown

Original languageEnglish
Pages (from-to)71-77
Number of pages7
JournalPulmonary Pharmacology and Therapeutics
Volume23
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Polymorphism
Adrenergic Receptors
Genes
Lung
Genetic Promoter Regions
Proteins
Genotype
Crowns
Single Nucleotide Polymorphism
Nucleotides
Tissue
Amino Acids
Scanning electron microscopy

Cite this

Kay, Linda J. ; Suvarna, S. Kim ; Scola, Anne Marie ; Rostami-Hodjegan, Amin ; Chess-Williams, Russell ; Peachell, Peter T. / Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor expression in human lung. In: Pulmonary Pharmacology and Therapeutics. 2010 ; Vol. 23, No. 2. pp. 71-77.
@article{5499f45e899444cc96011585a327531f,
title = "Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor expression in human lung",
abstract = "Background: The aim of the present study was to establish whether polymorphisms, especially those within the promoter region, of the β2-adrenoceptor gene (ADRB2) influence β2-adrenoceptor expression in human lung. Methods: The density of β-adrenoceptors in human lung tissue (n = 88) was determined by saturation binding using the radioligand, iodinated cyanopindolol. Discrimination of β1- and β2-adrenoceptors was determined using the highly selective β1-adrenoceptor antagonist, CGP20712A. Genotype was determined at 5 positions of ADRB2 previously reported as polymorphic. Potential influences of single nucleotide polymorphisms (SNPs) within the promoter region (-367, -47) and coding block (46, 79, 491) of ADRB2 on β2-adrenoceptor expression were investigated. Results: The density of β2-adrenoceptors was variable among the 88 lung preparations studied ranging from 17 to 177 fmol/mg protein (mean ± S.E.M., 72 ± 4 fmol/mg protein). There was no influence of genotype on β2-adrenoceptor expression for any of the polymorphisms studied except at position 491. The polymorphism at position 491C > T, leading to a change from thr to ile at amino acid 164, is uncommon. Preparations genotyped as heterozygous (126 ± 15 fmol/mg protein; n = 5) expressed significantly (P = 0.0005) higher levels of β2-adrenoceptor than those that were homozygous (69 ± 4 fmol/mg protein; n = 83). Conclusion: With the exception of position 491, these data indicate that polymorphisms of ADRB2 do not influence β2-adrenoceptor expression in human lung. Crown",
author = "Kay, {Linda J.} and Suvarna, {S. Kim} and Scola, {Anne Marie} and Amin Rostami-Hodjegan and Russell Chess-Williams and Peachell, {Peter T.}",
year = "2010",
month = "4",
doi = "10.1016/j.pupt.2009.10.013",
language = "English",
volume = "23",
pages = "71--77",
journal = "Pulmonary Pharmacology",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "2",

}

Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor expression in human lung. / Kay, Linda J.; Suvarna, S. Kim; Scola, Anne Marie; Rostami-Hodjegan, Amin; Chess-Williams, Russell; Peachell, Peter T.

In: Pulmonary Pharmacology and Therapeutics, Vol. 23, No. 2, 04.2010, p. 71-77.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor expression in human lung

AU - Kay, Linda J.

AU - Suvarna, S. Kim

AU - Scola, Anne Marie

AU - Rostami-Hodjegan, Amin

AU - Chess-Williams, Russell

AU - Peachell, Peter T.

PY - 2010/4

Y1 - 2010/4

N2 - Background: The aim of the present study was to establish whether polymorphisms, especially those within the promoter region, of the β2-adrenoceptor gene (ADRB2) influence β2-adrenoceptor expression in human lung. Methods: The density of β-adrenoceptors in human lung tissue (n = 88) was determined by saturation binding using the radioligand, iodinated cyanopindolol. Discrimination of β1- and β2-adrenoceptors was determined using the highly selective β1-adrenoceptor antagonist, CGP20712A. Genotype was determined at 5 positions of ADRB2 previously reported as polymorphic. Potential influences of single nucleotide polymorphisms (SNPs) within the promoter region (-367, -47) and coding block (46, 79, 491) of ADRB2 on β2-adrenoceptor expression were investigated. Results: The density of β2-adrenoceptors was variable among the 88 lung preparations studied ranging from 17 to 177 fmol/mg protein (mean ± S.E.M., 72 ± 4 fmol/mg protein). There was no influence of genotype on β2-adrenoceptor expression for any of the polymorphisms studied except at position 491. The polymorphism at position 491C > T, leading to a change from thr to ile at amino acid 164, is uncommon. Preparations genotyped as heterozygous (126 ± 15 fmol/mg protein; n = 5) expressed significantly (P = 0.0005) higher levels of β2-adrenoceptor than those that were homozygous (69 ± 4 fmol/mg protein; n = 83). Conclusion: With the exception of position 491, these data indicate that polymorphisms of ADRB2 do not influence β2-adrenoceptor expression in human lung. Crown

AB - Background: The aim of the present study was to establish whether polymorphisms, especially those within the promoter region, of the β2-adrenoceptor gene (ADRB2) influence β2-adrenoceptor expression in human lung. Methods: The density of β-adrenoceptors in human lung tissue (n = 88) was determined by saturation binding using the radioligand, iodinated cyanopindolol. Discrimination of β1- and β2-adrenoceptors was determined using the highly selective β1-adrenoceptor antagonist, CGP20712A. Genotype was determined at 5 positions of ADRB2 previously reported as polymorphic. Potential influences of single nucleotide polymorphisms (SNPs) within the promoter region (-367, -47) and coding block (46, 79, 491) of ADRB2 on β2-adrenoceptor expression were investigated. Results: The density of β2-adrenoceptors was variable among the 88 lung preparations studied ranging from 17 to 177 fmol/mg protein (mean ± S.E.M., 72 ± 4 fmol/mg protein). There was no influence of genotype on β2-adrenoceptor expression for any of the polymorphisms studied except at position 491. The polymorphism at position 491C > T, leading to a change from thr to ile at amino acid 164, is uncommon. Preparations genotyped as heterozygous (126 ± 15 fmol/mg protein; n = 5) expressed significantly (P = 0.0005) higher levels of β2-adrenoceptor than those that were homozygous (69 ± 4 fmol/mg protein; n = 83). Conclusion: With the exception of position 491, these data indicate that polymorphisms of ADRB2 do not influence β2-adrenoceptor expression in human lung. Crown

UR - http://www.scopus.com/inward/record.url?scp=75749087525&partnerID=8YFLogxK

U2 - 10.1016/j.pupt.2009.10.013

DO - 10.1016/j.pupt.2009.10.013

M3 - Article

VL - 23

SP - 71

EP - 77

JO - Pulmonary Pharmacology

JF - Pulmonary Pharmacology

SN - 1094-5539

IS - 2

ER -